Morphinan ring system

An attempt has been made to synthesize the morphinane ring-system in this way, and l-(/3-diethylaminoethyl)-2-keto-1 2 3 4-tetrahydro-naphthalene was converted to [oxxvm] by condensation with the appropriate Mannich base methiodide, the product brominated with N-bromosuccinimide, and finally converted to the quaternary salt [cxxix]. Work on the corresponding N-dimethyl series was abandoned when it was found impossible to obtain the requisite substituted /3-tetralone in a state even approaching purity. The synthesis of [cxxx] has been accomplished by the same method, its production being accompanied by the production of [cxxxi] as a result of further ring-extension [43]. 

The synthesis by Grewe of the morphinane ring system depends on a reversal of this process. As explained elsewhere, this scheme allows of a particularly close relation between sinomenine and a laudanosine derivative. The latter was synthesized and hopefully called proto-Hinomcnine, but it has not been available in sufficient amount to enable its properties and possible transformation to sinomenine to be thoroughly examined. 

TRK-851 is a clinical candidate for an antitussive drug it has a novel, complex morphinan ring system. The development of TRK-851 was motivated by the finding that NTI, a selective 8 opioid receptor antagonist, showed antitussive effect. In this section we will describe the process of developing TRK-851, including the structure-activity relationship (SAR) studies on NTI derivatives and the difficulties encountered in overcoming a defect in the metabolism of a prototype clinical candidate, TRK-850. 

Applications to alkaloid synthesis are exemplified by the construction of the morphinan ring system (I) and synthesis of the oxocrinine analog (II). 

Opium, the sun-dried latex of the unripe fruit of Papaver somniferum, cultivated from early times for this drug, contains at least 23 alkaloids. Of the major alkaloids three—morphine, codeine, and thebaine—contain the morphinan ring system. 

Many of the comments in this section are reflected in structure-activity discussions on morphinans and benzomorphans. In the case of 4,5-epoxymorphinans, variation of the N-substituent and changes in the form (rigidity and conformation) of the ring system and the nature of substituents bring about dramatic qualitative and quantitative changes in biological responses. 

---